EP 0543871 A1 19930602 - STABLE DOXORUBICIN/LIPOSOME COMPOSITION.
Title (en)
STABLE DOXORUBICIN/LIPOSOME COMPOSITION.
Title (de)
STABILE DOXORUBICIN/LIPOSOM ZUSAMMENSETZUNG.
Title (fr)
COMPOSITION DE DOXORUBICINE/LIPOSOME STABLE.
Publication
Application
Priority
US 56407090 A 19900808
Abstract (en)
[origin: WO9202208A1] A lyophilized doxorubicin/lipid composition which is stable against doxorubicin breakdown on storage. The composition is formed by lyophilizing a doxorubicin liposome suspension having a pH between 3.0 and 4.4.
Abstract (fr)
Composition de doxorubicine/lipide lyophilisée ne souffrant pas de la dégradation de la doxorubicine lors du stockage. La composition est formée par lyophilisation d'une suspension de liposomes de doxorubicine ayant un pH compris entre 3,0 et 4,4.
IPC 1-7
IPC 8 full level
A61K 9/127 (2006.01); A61K 31/70 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 9/127 (2013.01); A61K 31/70 (2013.01); A61P 35/00 (2017.12)
Citation (search report)
See references of WO 9202208A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9202208 A1 19920220; AU 8329391 A 19920302; CA 2088975 A1 19920209; EP 0543871 A1 19930602; JP H06502623 A 19940324
DOCDB simple family (application)
US 9105519 W 19910802; AU 8329391 A 19910802; CA 2088975 A 19910802; EP 91914508 A 19910802; JP 51413991 A 19910802